At NVision, we engineer quantum-powered medical imaging technologies that deliver deeper, more precise MRI data for researchers and clinicians. Our unique hyperpolarization device POLARIS enables fast, simple, scalable imaging of metabolism at the cellular level. With hyperpolarized MRI, we are paving the way for earlier detection, faster treatment assessment and better risk profiling in oncology, cardiology, neurology and beyond.
$1.5M sweet spot round size
2015
$1.5M
from investors over 1 rounds
NVision Imaging Technologies raised $1.5M on February 1, 2025